MedPath

Evaluation of the Endometrial Cavity After Endometrial Ablation

Not Applicable
Terminated
Conditions
Menorrhagia
Registration Number
NCT02087228
Lead Sponsor
Baylor Research Institute
Brief Summary

The purpose of this study is to evaluate the shape, size and appearance of the inside of the uterus six months following an endometrial ablation procedure. Half of the participants will have their ablation performed with a hydrothermal ablation device and the other half will have their ablation performed with a device that uses radiofrequency energy.

Detailed Description

The purpose of this study is to evaluate the shape, size and appearance of the inside of the uterus six months following an endometrial ablation procedure. Half of the participants will have their ablation performed with a hydrothermal ablation device and the other half will have their ablation performed with a device that uses radiofrequency energy. Participants are randomly assigned to one or the other device.

A vaginal ultrasound will be performed before the procedure and again at six months post-procedure.

The inside of the uterus will be visualized via hysteroscopy before the procedure and again at six months post-procedure. Measurements will be taken and the investigator will compare photos taken pre-procedure and six months post-procedure.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
25
Inclusion Criteria
  • Premenopausal women Not pregnant and no future pregnancy desired Willing to randomize the device used for the ablation Willing to undergo diagnostic hysteroscopy with office-based anesthesia 6 months post-ablation
Exclusion Criteria
  • Pregnancy or desiring future pregnancy Endometrial hyperplasia Presence of active endometriosis Active pelvic inflammatory disease Previous endometrial ablation procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Visualization of the inside of the uterus6 months post-ablation

The inside of the uterus will be visualized via hysteroscopy to determine the amount of scarring

Secondary Outcome Measures
NameTimeMethod
Measurments of endometrial thickness6 months post-ablation

Measurements will be taken of the uterine cavity length and endometrial thickness

Trial Locations

Locations (1)

Texas Health Care

πŸ‡ΊπŸ‡Έ

Fort Worth, Texas, United States

Texas Health Care
πŸ‡ΊπŸ‡ΈFort Worth, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.